Sonnet BioTherapeutics Holdings, Inc. (SONN) NASDAQ

1.26

-1.84(-59.35%)

Updated at December 02 04:00PM

Currency In USD

Valuation

Market Cap4.38M
Enterprise Value4.36M
P/E Ratio-0.37
PEG Ratio-0.01
Price/Sales Ratio8.43
Price/Book Ratio-1.64
Enterprise/Revenue8.18
Enterprise/EBITDA-0.59

Fiscal Year

Fiscal YearSeptember 30, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-13.56
Operating Margin-14.06

Management Effectiveness

Return On Assets-6.6
Return On Equity-46.48

Income Statement

Revenue1M
Revenue/Share0.25
Gross Profit0
EBITDA-15.84M
Net Income-16.11M
Diluted EPS-3.95

Balance Sheet

Total Cash321,297
Total Cash/Share0.08
Total Debt68,837
Total Debt/Equity-0.02
Current Ratio0.26
Book Value Per Share-0.77

Price History

52-Week Change-11.27
52-Week High19.3
52-Week Low1.08
Moving Average 50 Days4.58
Moving Average 200 Days3.04

Statistics

Average Volume1.11M
Shares Outstanding6.69M
% Held by Institutions610.28

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:8
Last Split DateSeptember 30, 2024